SUS
Brazil's Fiocruz, through its Farmanguinhos unit, has begun fully domestic production of tacrolimus, an immunosuppressant to prevent organ transplant rejection. The milestone stems from a Product Development Partnership (PDP) with Brazilian firm Libbs, which acquired manufacturing technology from India's Biocon. Farmanguinhos now becomes the sole supplier to the SUS public health system.
Rapporteret af AI
Brazil's Ministry of Health announced on Monday, December 22, 2025, that Rede D'Or has joined the Agora Tem Especialistas program to cut wait times for consultations and procedures in the SUS public health system. Two private network units in Rio de Janeiro and Niterói will perform about 100 cardiac surgeries annually for public patients, valued at R$ 3.6 million. In exchange, hospitals receive tax credits to offset federal taxes.